RT Journal Article
T1 Mesalazine induced interstitial pneumonitis in the COVID era.
A1 Aparicio Serrano, Ana
A1 Gallego Jimenez, Elma
A1 Castro Rodriguez, Javier
A1 Soto Escribano, Pilar
A1 Iglesias Flores, Eva
A1 Marin Pedrosa, Sandra
A1 Benitez, Jose Manuel
K1 Mesalazine
K1 Lung injury
K1 Ulcerative colitis
AB Mesalazine is the most widely used aminosalicylate for induction and maintenance of remission in patients with mild-to-moderate ulcerative colitis (UC). Drug-induced hypersensitivity pneumonitis is considered very rare (< 1/10 000 patients).
PB Sociedad Espanola de Patologia Digestiva
SN 1130-0108
YR 2022
FD 2022
LK http://hdl.handle.net/10668/21728
UL http://hdl.handle.net/10668/21728
LA en
NO Serrano AA, Jiménez EG, Rodríguez JC, Escribano PS, Flores EI, Pedrosa SM, et al. Mesalazine induced interstitial pneumonitis in the COVID era. Revista Española de Enfermedades Digestivas [Internet]. 1 de enero de 2022
DS RISalud
RD Apr 18, 2025